Laszlo Rosivall
Overview
Explore the profile of Laszlo Rosivall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
1846
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keller F, Denicolo S, Leierer J, Kruus M, Heinzel A, Kammer M, et al.
Kidney Blood Press Res
. 2024 Nov;
49(1):1013-1025.
PMID: 39510044
Introduction: Diabetic kidney disease (DKD) is a common cause of chronic kidney disease with around 25-40% of patients with diabetes being affected. The course of DKD is variable, and estimated...
2.
Cseprekal O, Rosivall L
Ren Fail
. 2024 Apr;
46(1):2282709.
PMID: 38682163
Budapest Nephrology School (BNS) could have celebrated its 30th event if it had not been interrupted by COVID pandemic for a few years. Yet, the organization of 27th BNS in...
3.
Denicolo S, Reinstadler V, Keller F, Thoni S, Eder S, Heerspink H, et al.
Diabetologia
. 2024 Apr;
67(7):1283-1294.
PMID: 38647650
Aims/hypothesis: Non-adherence to medication is a frequent barrier in the treatment of patients with type 2 diabetes mellitus, potentially limiting the effectiveness of evidence-based treatments. Previous studies have mostly relied...
4.
Thoni S, Keller F, Denicolo S, Eder S, Buchwinkler L, Rosivall L, et al.
Kidney Blood Press Res
. 2023 Apr;
48(1):165-174.
PMID: 37015210
Introduction: Type 2 diabetes and its complications represent a huge burden to public health. With this prospective, observational cohort study, we aimed to estimate and to compare the incidence rate...
5.
Kopitko C, Rosivall L, Medve L, Gondos T, Soliman K, Szabo Z, et al.
ASAIO J
. 2022 Dec;
69(2):e54-e65.
PMID: 36521162
An increased intraabdominal pressure, particularly when occurring during periods of hemodynamic instability or fluid overload, is regarded as a major contributor to acute kidney injury (AKI) in intensive care units....
6.
Kokeny G, Nemeth A, Kopp J, Chen W, Oler A, Manzeger A, et al.
Kidney Int
. 2022 May;
102(2):337-354.
PMID: 35513123
Patients with chronic kidney disease and experimental animal models of kidney fibrosis manifest diverse progression rates. Genetic susceptibility may contribute to this diversity, but the causes remain largely unknown. We...
7.
Denicolo S, Vogi V, Keller F, Thoni S, Eder S, Heerspink H, et al.
Kidney Int Rep
. 2022 May;
7(4):876-888.
PMID: 35497780
Introduction: The disease trajectory of diabetic kidney disease (DKD) shows a high interindividual variability not sufficiently explained by conventional risk factors. Clonal hematopoiesis of indeterminate potential (CHIP) is a proposed...
8.
Petho A, Piecha D, Meszaros T, Urbanics R, Moore C, Canaud B, et al.
Ren Fail
. 2021 Dec;
43(1):1609-1620.
PMID: 34882053
Hemodialysis reactions (HDRs) resemble complement-activation-related pseudoallergy (CARPA) to certain i.v. drugs, for which pigs provide a sensitive model. On this basis, to better understand the mechanism of human HDRs, we...
9.
Csepe P, Dinya E, Balazs P, Hosseini S, Kuzdy G, Rosivall L
Z Gesundh Wiss
. 2021 Nov;
:1-7.
PMID: 34725631
Background: The COVID-19 pandemic brought quick, severe and unexpected changes to our everyday life and also changed the traditional education pattern of Semmelweis University in the middle of academic year...
10.
Kerschbaum J, Rudnicki M, Dzien A, Dzien-Bischinger C, Winner H, Heerspink H, et al.
Sci Rep
. 2020 Nov;
10(1):19743.
PMID: 33184434
Studies reporting on biomarkers aiming to predict adverse renal outcomes in patients with type 2 diabetes and kidney disease (DKD) conventionally define a surrogate endpoint either as a percentage of...